Protara Beats Q2 Loss Estimates
Protara Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $4.52
+13% in 3d after detection
Post-detection moves
1h
—
1d
+9.7%
3d
+13%
7d
+7.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS